Aziza Khikmatullaeva is currently working in Research Institute of Virology, Tashkent

General Education :

2010      Senior Scientific Researcher

2009      Doctor of Philosophy (PhD)

2018      Doctor of Science (DSc)

1992-1998           The Second Tashkent State Medical Institute General medicine

Work Experience :

2004      Research Institute of Virology clinical residency

2006      Research Institute of Virology, Tashkent, junior scientific researcher in the clinical   department.

2007      Research Institute of Virology postgraduate student

2009      Research Institute of Virology, Tashkent Scientific Secretary of the Virology Research Institute.

2008      Defended her PhD thesis on "Viral hepatitis C in injecting drug users (clinical and virological aspects)"

2018      Defended her doctoral dissertation on the topic "Liver cirrhosis HBV, HDV etiology (clinic, diagnosis and prognosis taking into account the economic burden)"

2018-present      Research Institute of Virology, Tashkent, Deputy Director for Scientific Work

2020--present    Head of the applied project "Creation of technology for the control and treatment of coronavirus infections based on an in-depth analysis of pathogenesis".

Trainings and courses :

 2011     Tashkent Institute of post-graduate medical education selected issues of infectious diseases

2013      Tashkent Institute of post-graduate medical education Epidemiology, etiology, clinic, profilactics of arbovirus infections and diagnosis of polymerase chain reaction

2015      Tashkent Institute of post-graduate medical education Laboratory diagnostics of arbovirus infection

2019      Republican institute of higher education Training internship in Minsk (Belarus)

2019      APASL Conference “Delta Hepatitis”, Azerbaijan, Baku Certificate

2020      Republican institute of higher education, Improvement of processes in the work of diagnostic laboratories

2020      Republican institute of higher education, Infectious diseases

2020      Republican institute of higher education,Actual questions of coronavirus and other respiratory infections

Projects :

2005-2007           Research Institute of Virology, Tashkent

Features of the clinical course, development of tactics for the treatment of patients with chronic hepatitis C who have injected drugs

2003-2007           Mechanism of formation of the infectious process in viral hepatitis B and C and outcomes depending on the genotype of the virus (virology, immunology, clinic)

2009-2011           Development of methods for predicting the effectiveness of antiviral treatment and outcomes of chronic viral hepatitis C depending on the polymorphism of certain genetic factors

2009-2011           Epidemiological prevalence of parenteral and sexually transmitted infections in injecting drug users and improvement of specific methods of prevention and treatment

2012-2014           Development of new approaches to the prediction, treatment and prevention of the transition of chronic viral hepatitis to liver cirrhosis based on the identification of IL28B gene polymorphism and serum markers of liver fibrosis

2020-2022           Creation of technology for the control and treatment of coronavirus infections based on an in-depth analysis of pathogenesis

Publications :

               Totally published more than 189 scientific papers: 4 of them monographs. Main topics on viral hepatitis, cirrhosis of the liver, COVID-19

Languages :

               Russian (native); Uzbek (native); English (pre-intermediate)